China Very Small Embryonic Like Stem Cells Market Size & Outlook

The very small embryonic like stem cells market in China is expected to reach a projected revenue of US$ 85.8 million by 2030. A compound annual growth rate of 17% is expected of China very small embryonic like stem cells market from 2024 to 2030.
Revenue, 2023 (US$M)
$28.5
Forecast, 2030 (US$M)
$85.8
CAGR, 2024 - 2030
17.1%
Report Coverage
China

China very small embryonic like stem cells market, 2018-2030 (US$M)

China

Related Markets

China very small embryonic like stem cells market highlights

  • The China very small embryonic like stem cells market generated a revenue of USD 28.5 million in 2023 and is expected to reach USD 85.8 million by 2030.
  • The China market is expected to grow at a CAGR of 17% from 2024 to 2030.
  • In terms of segment, regenerative medicine was the largest revenue generating application in 2023.
  • Drug Discovery & Development is the most lucrative application segment registering the fastest growth during the forecast period.

Very small embryonic like stem cells market data book summary

Market revenue in 2023USD 28.5 million
Market revenue in 2030USD 85.8 million
Growth rate17% (CAGR from 2023 to 2030)
Largest segmentRegenerative medicine
Fastest growing segmentDrug Discovery & Development
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationRegenerative Medicine, Drug Discovery & Development
Key market players worldwideSTEMCELL Technologies, CellGenix, PromoCell GmbH, Lonza Group Ltd, Celgene, Brainstorm Cell Therapeutics Inc, Osiris Therapeutics, Genea Biomedx, Takeda Pharmaceutical Co Ltd, Gamida Cell, Century Therapeutics Inc, MaxCyte Inc, Kite Pharma, Cellartis, Genea, Waisman Biomanufacturing, Bioheart

Other key industry trends

  • In terms of revenue, China accounted for 5.3% of the global very small embryonic like stem cells market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China very small embryonic like stem cells market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 85.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Very Small Embryonic Like Stem Cells Market Companies

Name Profile # Employees HQ Website

China very small embryonic like stem cells market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to very small embryonic like stem cells market will help companies and investors design strategic landscapes.


Regenerative medicine was the largest segment with a revenue share of 90.53% in 2023. Horizon Databook has segmented the China very small embryonic like stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.


  • China Very Small Embryonic Like Stem Cells Application Outlook (Revenue, USD Million, 2018-2030)
    • Regenerative Medicine
    • Drug Discovery & Development

Reasons to subscribe to China very small embryonic like stem cells market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China very small embryonic like stem cells market databook

  • Our clientele includes a mix of very small embryonic like stem cells market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China very small embryonic like stem cells market , including forecasts for subscribers. This country databook contains high-level insights into China very small embryonic like stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China very small embryonic like stem cells market size, by application, 2018-2030 (US$M)

China Very Small Embryonic Like Stem Cells Market Outlook Share, 2023 & 2030 (US$M)

China very small embryonic like stem cells market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more